Multiple sclerosis (MS) is a neurological disease that causes symptoms like fatigue, impaired mobility, and speech issues. The most common types are RRMS or PPMS, each with different symptom timing ...

Symptoms of PPMS progress from the time they first appear without remissions. Symptoms may include balance issues, cognitive decline, and muscle weakness, among others. Multiple sclerosis (MS) is an ...

The FDA has rejected Sanofi's application seeking approval of tolebrutinib to treat certain forms of MS in its present form.

If you have primary progressive multiple sclerosis (PPMS), you probably first saw a doctor because your legs were weak or you had trouble walking. Those are the most common symptoms of this type of MS ...

Findings showed treatment with tolebrutinib did not significantly delay disability progression compared with placebo. A phase 3 study evaluating tolebrutinib for the treatment of primary progressive ...

Being diagnosed with any incurable disease is distressing, but there are ways to improve your quality of life when living with PPMS. Typically, people with PPMS do not have distinct periods of relapse ...

Ocrelizumab and hyaluronidase is now the first and only twice-yearly subcutaneous injection approved for relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS). The ...

In recent years, some investors have been turning to alternative investment opportunities as a complement to traditional stocks or bonds. In order to launch a private security option for investors, a ...

Primary progressive multiple sclerosis (PPMS) is an uncommon form of MS that affects approximately 10-15% of MS patients. In PPMS, symptoms steadily get worse over time without frequent relapses or ...